GOLDEN AGRI-RESOURCES LTD
Half Year Financial Statement And Dividend Announcement
FINANCIAL HIGHLIGHTS
1st Half | 1st Half | 2nd Qtr | 2nd Qtr | |||
2019 | 2018 | Change | 2019 | 2018 | Change | |
US$'000 | US$'000 | % | US$'000 | US$'000 | % | |
Revenue | 3,166,532 | 3,676,231 | (13.9) | 1,549,237 | 1,860,059 | (16.7) |
Gross Profit | 344,568 | 468,029 | (26.4) | 151,806 | 219,909 | (31.0) |
EBITDA1 | 197,934 | 237,936 | (16.8) | 77,295 | 116,802 | (33.8) |
Underlying | ||||||
(loss)/profit 2 | (15,338) | 41,380 | n.m. | (27,106) | 16,592 | n.m. |
Underlying | ||||||
(loss)/profit per | ||||||
share (USD cents) | (0.12) | 0.32 | n.m. | (0.21) | 0.13 | n.m. |
Net loss attributable | ||||||
to owners of the | ||||||
Company | (46,387) | (27,171) | 70.7 | (64,701) | (39,022) | 65.8 |
Notes:
- Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortisation, net gain/(loss) from changes in fair value of biological assets, foreign exchange gain/(loss) and exceptional item.
- Net profit/(loss) attributable to owners of the Company excluding net effect of net gain or loss from changes in fair value of biological assets and depreciation of bearer plants, exceptional item and other non-operating items (foreign exchange gain or loss, net tax impact from tax-based asset revaluations, and other deferred tax income or expense).
- n.m. - not meaningful.
1
PART I - INFORMATION REQUIRED FOR QUARTERLY (Q1, Q2 & Q3), HALF-YEAR AND FULL YEAR ANNOUNCEMENTS
1(a) An income statement and statement of comprehensive income for the group together with a comparative statement for the corresponding period of the immediately preceding financial year
UNAUDITED CONSOLIDATED INCOME STATEMENT
FOR THE PERIOD ENDED 30 JUNE 2019
1st Half | 1st Half | 2nd Qtr | 2nd Qtr | ||||||
2019 | 2018 | Change | 2019 | 2018 | Change | ||||
US$'000 | US$'000 | % | US$'000 | US$'000 | % | ||||
Revenue | 3,166,532 | 3,676,231 | (13.9) | 1,549,237 | 1,860,059 | (16.7) | |||
Cost of sales | (2,821,964) | (3,208,202) | (12.0) | (1,397,431) | (1,640,150) | (14.8) | |||
Gross Profit | 344,568 | 468,029 | (26.4) | 151,806 | 219,909 | (31.0) | |||
Operating expenses | |||||||||
Selling expenses | (173,240) | (258,671) | (33.0) | (82,708) | (127,391) | (35.1) | |||
General and administrative | |||||||||
expenses | (150,203) | (149,392) | 0.5 | (79,637) | (73,380) | 8.5 | |||
Total operating expenses | (323,443) | (408,063) | (20.7) | (162,345) | (200,771) | (19.1) | |||
Operating profit/(loss) | 21,125 | 59,966 | (64.8) | (10,539) | 19,138 | n.m. | |||
Other income/(expenses) | |||||||||
Financial income | 10,801 | 18,758 | (42.4) | 5,001 | 9,520 | (47.5) | |||
Financial expenses | (81,859) | (77,329) | 5.9 | (40,036) | (40,111) | (0.2) | |||
Share of results of associated | |||||||||
companies, net of tax | 3,097 | 420 | 637.4 | 166 | 532 | (68.8) | |||
Share of results of joint ventures, | |||||||||
net of tax | (7,663) | (9,110) | (15.9) | (4,734) | (6,099) | (22.4) | |||
Foreign exchange gain/(loss) | 3,171 | (17,140) | n.m. | (15,036) | (22,213) | (32.3) | |||
Other operating income | 15,017 | 10,693 | 40.4 | 6,570 | 8,059 | (18.5) | |||
(57,436) | (73,708) | (22.1) | (48,069) | (50,312) | (4.5) | ||||
Exceptional item | |||||||||
Gain on disposal of subsidiaries | 11,492 | - | n.m. | 43 | - | n.m. | |||
Loss before tax | (24,819) | (13,742) | 80.6 | (58,565) | (31,174) | 87.9 | |||
Tax | (10,503) | (10,581) | (0.7) | (2,879) | (6,579) | (56.2) | |||
Loss for the period | (35,322) | (24,323) | 45.2 | (61,444) | (37,753) | 62.8 | |||
Attributable to: | |||||||||
Owners of the Company | (46,387) | (27,171) | 70.7 | (64,701) | (39,022) | 65.8 | |||
Non-controlling interests | 11,065 | 2,848 | 288.5 | 3,257 | 1,269 | 156.7 | |||
(35,322) | (24,323) | 45.2 | (61,444) | (37,753) | 62.8 |
Note:
(1) n.m. - not meaningful.
2
UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 30 JUNE 2019
1st Half | 1st Half | 2nd Qtr | 2nd Qtr | |||||
2019 | 2018 | 2019 | 2018 | |||||
US$'000 | US$'000 | US$'000 | US$'000 | |||||
Loss for the period | (35,322) | (24,323) | (61,444) | (37,753) | ||||
Other comprehensive income/(loss): | ||||||||
Items that will not be reclassified subsequently to | ||||||||
profit or loss: | ||||||||
Actuarial (loss)/gain on post-employment benefits | (5,707) | 6,000 | (5,707) | 6,000 | ||||
Share of other comprehensive income of a joint venture | 1 | - | - | 44 | ||||
Changes in fair value of financial assets at fair value | ||||||||
through other comprehensive income | 40,028 | - | 32,743 | - | ||||
Items that may be reclassified subsequently to | ||||||||
profit or loss: | ||||||||
Foreign currency translation differences on | ||||||||
consolidation | 3,136 | (16,315) | 128 | (18,422) | ||||
Share of other comprehensive income/(loss) of: | ||||||||
Joint ventures | 210 | (2,056) | (170) | (1,460) | ||||
Associates | (291) | - | 472 | - | ||||
Changes in fair value of available-for-sale financial | ||||||||
assets | - | 98 | - | 1,567 | ||||
Other comprehensive income/(loss), net of tax | 37,377 | (12,273) | 27,466 | (12,271) | ||||
Total comprehensive income/(loss) for the period, | ||||||||
net of tax | 2,055 | (36,596) | (33,978) | (50,024) | ||||
Total comprehensive (loss)/income attributable to: | ||||||||
Owners of the Company | (9,543) | (38,410) | (37,117) | (50,708) | ||||
Non-controlling interests | 11,598 | 1,814 | 3,139 | 684 | ||||
2,055 | (36,596) | (33,978) | (50,024) |
ADDITIONAL INFORMATION
Earnings before tax, non-controlling interests, interest on borrowings, depreciation and amortisation, net loss from changes in fair value of biological assets, foreign exchange gain/(loss) and exceptional item ("EBITDA")
1st Half | 1st Half | 2nd Qtr | 2nd Qtr | ||||||
2019 | 2018 | Change | 2019 | 2018 | Change | ||||
US$'000 | US$'000 | % | US$'000 | US$'000 | % | ||||
Earnings before tax, non- | 197,934 | 237,936 | (16.8) | 77,295 | 116,802 | (33.8) | |||
controlling interests, interest on | |||||||||
borrowings, depreciation and | |||||||||
amortisation, net loss from | |||||||||
changes in fair value of | |||||||||
biological assets and foreign | |||||||||
exchange gain/(loss) and | |||||||||
exceptional item ("EBITDA") | |||||||||
Interest on borrowings | (81,081) | (76,086) | 6.6 | (39,806) | (39,553) | 0.6 | |||
Depreciation and amortisation | (153,323) | (142,524) | 7.6 | (77,028) | (71,093) | 8.3 | |||
Net loss from changes in fair value | (3,012) | (15,928) | (81.1) | (4,033) | (15,117) | (73.3) | |||
of biological assets | |||||||||
Foreign exchange gain/(loss) | 3,171 | (17,140) | n.m. | (15,036) | (22,213) | (32.3) | |||
Exceptional item | 11,492 | - | n.m. | 43 | - | n.m. | |||
Loss before tax | |||||||||
(24,819) | (13,742) | 80.6 | (58,565) | (31,174) | 87.9 | ||||
Note:
(1) n.m. - not meaningful.
3
1(b)(i) A statement of financial position (for the issuer and group), together with a comparative
statement as at the end of the immediately preceding financial year | |||||||||
UNAUDITED STATEMENTS OF FINANCIAL POSITION | |||||||||
Group | Company | ||||||||
As at | As at | As at | As at | ||||||
30/6/2019 | 31/12/2018 | 30/6/2019 | 31/12/2018 | ||||||
US$'000 | US$'000 | US$'000 | US$'000 | ||||||
Assets | |||||||||
Current Assets | |||||||||
Cash and cash equivalents | 120,426 | 192,766 | 32 | 88 | |||||
Short-term investments | 351,606 | 351,855 | - | - | |||||
Trade receivables | 501,209 | 533,692 | - | - | |||||
Other current assets (note (a)) | 895,993 | 804,835 | 46 | 11 | |||||
Inventories | 921,273 | 1,002,350 | - | - | |||||
2,790,507 | 2,885,498 | 78 | 99 | ||||||
Non-Current Assets | |||||||||
Long-term receivables and | |||||||||
assets (note (b)) | 239,879 | 323,525 | - | - | |||||
Long-term investments | 1,252,265 | 1,077,772 | 198,030 | 175,065 | |||||
Subsidiary companies | - | - | 3,431,521 | 3,431,355 | |||||
Associated companies | 20,344 | 17,546 | - | - | |||||
Joint ventures | 81,216 | 88,723 | - | - | |||||
Investment properties | 110 | 112 | - | - | |||||
Property, plant and equipment | 2,627,630 | 2,624,108 | - | - | |||||
Bearer plants | 1,058,889 | 1,092,166 | - | - | |||||
Right-of-use assets | 36,446 | - | - | - | |||||
Deferred tax assets | 254,545 | 244,023 | - | - | |||||
Intangible assets | 181,597 | 192,107 | - | - | |||||
5,752,921 | 5,660,082 | 3,629,551 | 3,606,420 | ||||||
Total Assets | 8,543,428 | 8,545,580 | 3,629,629 | 3,606,519 |
4
UNAUDITED STATEMENTS OF FINANCIAL POSITION (cont'd) | |||||||||
Group | Company | ||||||||
As at | As at | As at | As at | ||||||
30/6/2019 | 31/12/2018 | 30/6/2019 | 31/12/2018 | ||||||
US$'000 | US$'000 | US$'000 | US$'000 | ||||||
Liabilities and Equity | |||||||||
Current Liabilities | |||||||||
Short-term borrowings | 1,652,156 | 1,376,266 | - | - | |||||
Bonds and notes payable | 124,811 | 124,640 | - | - | |||||
Lease liabilities | 18,418 | - | - | - | |||||
Trade payables | 650,166 | 683,349 | - | - | |||||
Other payables (note(c)) | 313,670 | 287,748 | 118,746 | 40,789 | |||||
Taxes payable | 16,801 | 18,899 | - | - | |||||
2,776,022 | 2,490,902 | 118,746 | 40,789 | ||||||
Non-Current Liabilities | |||||||||
Bonds and notes payables | 110,946 | 109,971 | - | - | |||||
Long-term borrowings | 1,134,624 | 1,399,212 | - | - | |||||
Lease liabilities | 19,382 | - | - | - | |||||
Deferred tax liabilities | 83,092 | 78,080 | - | - | |||||
Long-term payables and | |||||||||
liabilities | 174,380 | 157,335 | - | - | |||||
1,522,424 | 1,744,598 | - | - | ||||||
Total Liabilities | 4,298,446 | 4,235,500 | 118,746 | 40,789 | |||||
Equity Attributable to Owners of the Company | |||||||||
Issued capital | 320,939 | 320,939 | 320,939 | 320,939 | |||||
Share premium | 1,216,095 | 1,216,095 | 1,850,965 | 1,850,965 | |||||
Treasury shares | (31,726) | (31,726) | (31,726) | (31,726) | |||||
Other paid-in capital | 184,318 | 184,318 | - | - | |||||
Other reserves | |||||||||
Option reserve | 31,471 | 31,471 | 31,471 | 31,471 | |||||
Currency translation reserve | (14,370) | (16,702) | - | - | |||||
Fair value reserve | 146,716 | 106,688 | 1,640 | 1,640 | |||||
PRC statutory reserve | 3,820 | 3,820 | - | - | |||||
Other reserve | 29,648 | 35,315 | - | - | |||||
197,285 | 160,592 | 33,111 | 33,111 | ||||||
Retained earnings | 2,216,362 | 2,318,426 | 1,337,594 | 1,392,441 | |||||
4,103,273 | 4,168,644 | 3,510,883 | 3,565,730 | ||||||
Non-Controlling Interests | 141,709 | 141,436 | - | - | |||||
Total Equity | 4,244,982 | 4,310,080 | 3,510,883 | 3,565,730 | |||||
Total Liabilities and Equity | 8,543,428 | 8,545,580 | 3,629,629 | 3,606,519 |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
gar - Golden Agri-Resources Ltd. published this content on 15 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 August 2019 23:51:04 UTC